A Powerful Tumor Catalytic Therapy by an Enzyme‐Nanozyme Cascade Catalysis (ENCAT) System
Small · 2025
DOI: 10.1002/smll.202409363 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, 2025. Verfasst von Min Zhou und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, College of Engineering and Applied Sciences, Nanjing National Laboratory of Microstructures, Jiangsu Key Labora…. Hauptthemen laut MEDLINE: Neoplasms, Nanoparticles. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: Fundamental Research Funds for the Central Universities, State Key Laboratory of Analytical Chemistry for Life Science, National Natural Science Foundation of China.
Abstract (Originalsprache)
Complexity of tumor and its microenvironment as obstacles often restrict traditional tumor therapies. Enzyme/nanozyme‐mediated catalytic therapy has been emerged, but the efficacy of single catalytic therapy is still moderate. Inspired by the concepts of catalytic and synergetic therapy, an enzyme‐nanozyme cascade catalysis (ENCAT)‐enhanced tumor therapy is developed. First, metal–organic framework (MOF) PCN222‐Mn (PM) and glucose oxidase (GOx) are chosen as nanozyme and natural enzyme, respectively. Then two assembled together to form enzyme‐nanozyme complex PCN222‐Mn@GOx (PMG). To achieve tumor targeting and GOx protection, hyaluronic acid (HA) is modified on PMG to obtain PCN222‐Mn@GOx/HA (PMGH). Both cellular and animal studies demonstrate a cascade catalysis‐enhanced tumor therapy by PMGH. Specifically, a cascade catalysis‐enhanced PDT is achieved based on enzyme‐nanozyme mediated cascade‐catalyzed O 2 generation; an enhanced synergistic therapy is demonstrated by combining PM‐mediated PDT, GOx‐mediated starvation therapy, and activated/promoted immunotherapy together. Additionally, the designed tumor catalytic therapy is explored in a tumor bearing mouse model, where it exhibits powerful anti‐tumor effects against both primary and metastatic tumors. This strategy has the potential to broaden tumor therapeutic approaches.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Engineering, College of Engineering and Applied Sciences, Nanjing National Laboratory of Microstructures, Jiangsu Key Laboratory of Artificial Functional Materials, Nanjing University, Nanjing,…
- Nanozyme Laboratory in Zhongyuan, Henan Academy of Innovations in Medical Science, Zhengzhou, Henan, 451163, P. R. China.
- State Key Laboratory of Analytical Chemistry for Life Science, School of Chemistry and Chemical Engineering, Chemistry and Biomedicine Innovation Center (ChemBIC), ChemBioMed Interdisciplinary Research Centre at Nanjing…
ORCID-Profile: Hui Wei
Förderung
- Fundamental Research Funds for the Central Universities
- State Key Laboratory of Analytical Chemistry for Life Science
- National Natural Science Foundation of China
Zitieren
APA
Zhou, M., Feng, J., Mei, Q., Li, T., Zhang, Y., Liu, W., & Wei, H. (2025). A Powerful Tumor Catalytic Therapy by an Enzyme‐Nanozyme Cascade Catalysis (ENCAT) System. Small. https://doi.org/10.1002/smll.202409363
Vancouver
Zhou M, Feng J, Mei Q, Li T, Zhang Y, Liu W, et al. A Powerful Tumor Catalytic Therapy by an Enzyme‐Nanozyme Cascade Catalysis (ENCAT) System. Small. 2025. doi:10.1002/smll.202409363
BibTeX
@article{Zhou2025,
author = {Zhou, Min and Feng, Jiayuan and Mei, Qi and Li, Tong and Zhang, Yihong and Liu, Wanling and Wei, Hui},
title = {A Powerful Tumor Catalytic Therapy by an Enzyme‐Nanozyme Cascade Catalysis (ENCAT) System},
journal = {Small},
year = {2025},
doi = {10.1002/smll.202409363}
}
EUVIMED